Su1839: CORTICOSTEROID SPARING EFFECTS OF TREATMENT WITH GUSELKUMAB IN PATIENTS WITH MODERATE TO SEVERELY ACTIVE CROHN’S DISEASE: PHASE 3 GALAXI 2/3 RESULTS THROUGH WEEK 48 | Publicación